Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer

RP Johnson, CK Ratnacaram, L Kumar, J Jose - Drug Resistance Updates, 2022 - Elsevier
Prostate cancer (PC) is the most prevalent male urogenital cancer worldwide. PC patients
presenting an advanced or metastatic cancer succumb to the disease, even after therapeutic …

Unraveling the mysteries of perineural invasion in benign and malignant conditions

HF Bahmad, S Gogola, M Rejzer, K Stoyanov… - Current …, 2023 - mdpi.com
Perineural invasion (PNI) is defined as the dissemination of neoplastic cells within the
perineural space. PNI can be a strong indicator of malignancy and is linked to poor …

Immunotherapy for metastatic prostate cancer: current and emerging treatment options

D Chakravarty, L Huang, M Kahn… - Urologic …, 2020 - urologic.theclinics.com
Cancer is a disease of major concern worldwide and is the second leading cause of
mortality. 1 The United States remains one of the countries with the highest incidence rates …

Cribriform pattern disease over‐represented in pelvic lymph node metastases identified on 68GA PSMA‐PET/CT

D Bolton, A Hong, N Papa, M Perera, B Kelly… - BJUI …, 2022 - Wiley Online Library
Objectives To determine whether any specific histologic subtype of prostate cancer was
preferentially represented in pelvic lymph node metastases identified on 68GA‐PSMA …

[HTML][HTML] Microfluidic Applications in Prostate Cancer Research

K Szewczyk, L Jiang, H Khawaja, CK Miranti, Y Zohar - Micromachines, 2024 - mdpi.com
Prostate cancer is a disease in which cells in the prostate, a gland in the male reproductive
system below the bladder, grow out of control and, among men, it is the second-most …

[HTML][HTML] Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study

YP Wu, SH Chen, ST Wang, XD Li, H Cai, YZ Lin… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Infiltrating ductal carcinoma (IDC) is a rare histologic subtype of prostate cancer. We
investigated the clinicopathological features and prognosis of IDC compared with acinar cell …

Immunohistochemical expression of ERG and P63 in some prostatic lesions

ASM Ibrahim, HAM Hasan… - The Egyptian Journal of …, 2019 - journals.ekb.eg
Background: prostate cancer (PCa) ranks second among the most common types of solid
tumors and the sixth among the leading causes of cancer deaths in men worldwide. In …

[PDF][PDF] Development of implementation recommendations to facilitate the routine collection of patient-reported outcome measures in prostate and gynaecological …

C Moss - 2023 - kclpure.kcl.ac.uk
Patient-reported outcomes (PROs) are an integral component of cancer clinical
management providing insight into the health status of patients. PROs are measured using …

[PDF][PDF] Genetic Diversity and Treatment Resistance in Prostate Cancer Cell Lines

L Donix - 2023 - core.ac.uk
7-AAD 7-Aminoactinomycin D ABCB1/C1/G2 ATP-binding cassette transporter B1/C1/G2
ABCT ATP-binding cassette transporter AD Adenocarcinoma ADT Androgen deprivation …

Kirurško liječenje karcinoma prostate

S Petrić - 2019 - unirepository.svkri.uniri.hr
Sažetak Karcinom prostate je najčešća maligna bolest među muškarcima u razvijenim
zemljama, a druga prema mortalitetu. Među muškarcima starije životne dobi predstavlja …